Showing results (231-240 of 300) with videos related to

Sort By:
Pageof 30
British Journal of Clinical Pharmacology|June 1, 1993
Cimetidine does not influence the metabolism of the H1-receptor antagonist ebastine to its active metabolite carebastineJ Van Rooij, H C Schoemaker, R Bruno, et al.
Clinical Pharmacology and Therapeutics|June 1, 1984
Nifedipine: kinetics and dynamics in healthy subjectsC H Kleinbloesem, P van Brummelen, J A van de Linde, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasiaM W Teunissen, G J Bruining, B M De Jongh, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humansA F Cohen, G S Land, D D Breimer, et al.
Pharmaceutical Research|February 1, 1990
Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in ratsE J van Hoogdalem, C D Heijligers-Feijen, J C Verhoef, et al.
British Journal of Pharmacology|January 1, 1990
Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual ratsJ Dingemanse, R A Voskuyl, M W Langemeijer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive ratsR A Mathôt, B C Van den Aarsen, W Soudijn, et al.
Pharmaceutical Research|July 24, 2001
P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrierI C van der Sandt, P J Gaillard, H H Voorwinden, et al.
Pageof 30